Inuprin

Inosine Pranobex, the active ingredient in Inuprin, is an immunomodulator presented as an oral formulation for systemic use. It is employed to support the immune response in various viral infections and in patients with compromised immunity. Clinical experience shows it can reduce the severity and duration of certain viral illnesses while enhancing natural killer cell activity.

GNH USA supplies Inuprin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Inuprin is an immunomodulatory antiviral used to manage infections that rely on host immune response. - Herpes simplex infections: shortens lesion healing time and decreases viral shedding. - Influenza and other acute viral infections: reduces symptom severity and accelerates recovery. - Subacute sclerosing panencephalitis (SSPE): may slow disease progression in affected patients. - Immunodeficiency support: enhances cellular immunity in individuals with weakened immune systems.

Adverse reactions may occur with Inuprin and are categorized by frequency.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: transient cranial discomfort. - Dizziness: occasional light‑headedness. - Abdominal discomfort: mild pain or cramping. - Rash: skin erythema or mild itching.

Serious or Rare Side Effects: - Severe allergic reactions: anaphylaxis or angioedema. - Hepatic dysfunction: elevated liver enzymes or hepatitis. - Hematologic abnormalities: leukopenia or thrombocytopenia. - Stevens‑Johnson syndrome: severe skin blistering. - Autoimmune phenomena: rare onset of autoimmune disorders.

Before initiating therapy, consider the following safety measures. - Assess immune status: evaluate baseline lymphocyte counts. - Monitor liver function: perform periodic hepatic enzyme tests. - Avoid in known hypersensitivity: discontinue if allergic signs appear. - Use with caution in renal impairment: adjust dosing if necessary. - Store at ambient temperature: keep in the original pack, protect from moisture.

Inuprin may interact with other medicines; awareness of the interaction level is essential.

Major Interactions (Avoid): - Concurrent immunosuppressants: may diminish therapeutic benefit. - Live vaccines: increased risk of vaccine‑derived infection.

Moderate Interactions (Monitor Closely): - Anticoagulants (e.g., warfarin): potential for enhanced bleeding. - Cytochrome P450 substrates: possible altered metabolism. - Other antiviral agents: may require dose adjustment or monitoring.